Erbb4 Signaling: an overlooked backup system?

Comment on: Canfield K, et al. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Cell Cycle 2015; 14(4):648-55; PMID:25590338; http://dx.doi.org/10.4161/15384101.2014.994966

Yingjia NiDepartment of Biological Sciences; University of Notre Dame, Notre Dame, IN, USA;Harper Cancer Research Institute; University of Notre Dame, South Bend, IN, USA

Siyuan ZhangDepartment of Biological Sciences; University of Notre Dame, Notre Dame, IN, USA;Harper Cancer Research Institute; University of Notre Dame, South Bend, IN, USACorrespondence[email protected]

References

Rimawi MF, et al. Annu Rev Med 2015; 66:111–28; PMID:25587647; http://dx.doi.org/10.1146/annurev-med-042513-015127
PubMed Web of Science ®Google Scholar
Xia W, et al. Cancer Res 2006; 66:1640–7; PMID:16452223; http://dx.doi.org/10.1158/0008-5472.CAN-05-2000
PubMed Web of Science ®Google Scholar
Mukai H. Int J Clin Oncol 2010; 15:335–40; PMID:20632056; http://dx.doi.org/10.1007/s10147-010-0107-0
PubMed Web of Science ®Google Scholar
Tvorogov D, et al. J Biol Chem 2009; 284:5582–91; PMID:19098003; http://dx.doi.org/10.1074/jbc.M805438200
PubMed Web of Science ®Google Scholar
Révillion F, et al. Eur J Cancer 1998; 34:791–808; http://dx.doi.org/10.1016/S0959-8049(97)10157-5
PubMed Web of Science ®Google Scholar
Canfield K, et al. Cell Cycle 2015 14(4):648–55; PMID:25590338; http://dx.doi.org/10.4161/15384101.2014.994966
PubMed Web of Science ®Google Scholar
Foulkes WD, et al. N Engl J Med 2010; 363:1938–48; PMID:21067385; http://dx.doi.org/10.1056/NEJMra1001389
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Erbb4 Signaling: an overlooked backup system?

Comment on: Canfield K, et al. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Cell Cycle 2015; 14(4):648-55; PMID:25590338; http://dx.doi.org/10.4161/15384101.2014.994966

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Erbb4 Signaling: an overlooked backup system?

Comment on: Canfield K, et al. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Cell Cycle 2015; 14(4):648-55; PMID:25590338; http://dx.doi.org/10.4161/15384101.2014.994966

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date